Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
about
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cellsPlatelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureUse of platelet lysate for bone regeneration - are we ready for clinical translation?Mesenchymal stem cells and immunomodulation: current status and future prospectsBioprocessing strategies for the large-scale production of human mesenchymal stem cells: a reviewMaking the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell ExpansionThe Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem CellsA xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical usesDonor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cellsDifferential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum.Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells.Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.The production method affects the efficacy of platelet derivatives to expand mesenchymal stromal cells in vitro.Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet releasateMesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathwayGMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage.High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells.Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo.Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cellsTherapeutic potential of human adipose-derived stem cells (ADSCs) from cancer patients: a pilot studyTranslating research into clinical scale manufacturing of mesenchymal stromal cells.Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness.Aggregation of Human Eyelid Adipose-derived Stem Cells by Human Body Fluids.Expression of blood group genes by mesenchymal stem cells.Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells.Assessment of an efficient xeno-free culture system of human periodontal ligament stem cells.Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viabilityAutologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion.Inflammatory response to nano- and microstructured hydroxyapatiteCulture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation.Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured Rats.Osteogenic Potential of Dental Mesenchymal Stem Cells in Preclinical Studies: A Systematic Review Using Modified ARRIVE and CONSORT Guidelines.Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease
P2860
Q21245484-7F19CDD3-326D-454C-ABC6-191B154A0255Q26740490-F337E3C5-CC03-431B-B73E-D89ADA67B8CEQ26765255-0A6F34CE-0602-4178-B3DA-E622C368D4CBQ26770191-5898C315-A822-4DEE-9C22-BA6DF2CF002BQ26776414-D411F518-496D-4028-BBF1-69DA6F4F9C0CQ28079988-82346908-F286-4E3A-B62D-FAFAA77CFEB5Q28534068-D0B66D1C-765D-4DEB-A33F-0BAC4F3861B2Q28534582-E48FD305-7107-4008-97AA-1B7F5197AA40Q28729211-522E9A45-5BC4-4ED0-8AE9-3F3E029AEE05Q30496289-7F96522A-B2DD-48EF-A642-FEE604FB5D91Q31068753-FB853951-7DD6-4A1F-9DCE-32385CBD4433Q33560685-D2C6D57D-814B-487D-8A96-49A46614644AQ33623503-5F395A56-814A-496B-B6DB-B10D269E0EFFQ33778870-54021A42-EF9B-47E5-B8FC-FCC5D09081E8Q34043379-64681DE5-C5D0-4D49-9FBE-E710A263588AQ34384920-50959C36-CB47-4FC6-BB70-D250C3A2D61FQ34391114-19CF3A1F-F115-436E-90A1-D50022F39C7FQ34422955-EFD6294A-D31B-4998-91A3-27674A8B42CAQ34428273-8111B634-BC9A-4CA9-B8FD-AA58FD8B60ADQ34475901-BCE617CD-21AF-4B4F-AB30-83413ACEE485Q34500457-C94F8ADC-3FCB-403B-9706-AD6E948DCCCFQ34507997-FA7CC537-DBFC-4A38-944E-A538309A0352Q34549948-7C4CDDD2-9593-4A7F-81A6-5272F51C9098Q34557484-3D3A4340-CB13-400D-BA28-C159C2DDB693Q34769510-5425044F-8CF6-4AC2-B3AF-EE53AD214960Q34804452-D560A0D9-E53D-4B7B-A50D-7557C3BEB422Q34827355-0898E17F-1BB2-4AC4-8624-E9A60B101681Q34852295-E543493C-A43C-4C98-8D2A-B37C574F4775Q34915107-517924A3-069C-40FD-A55F-B3006B617754Q34992282-C0FC2576-DDC6-4E26-B2BC-3A7AEB7C0AFBQ35078827-22742504-BA83-4535-98A6-0A9065BF12C9Q35137316-DA9A0D19-6609-4A4A-B110-5BAA91FAF003Q35250924-3FAF3590-BC1D-44D1-A0F0-E67DBEB9BD95Q35403742-6F9982B9-6E53-4EE3-A748-845C3FB72041Q35683429-4D3DF7F8-CCF1-4A48-AE06-6CED4D665FB5Q35690790-079690FF-98F3-46F9-9934-6DB88BFF19F1Q35730520-604E0429-1E7F-4F8B-89D3-01385F621E7DQ35768173-AF557630-D350-4134-BA80-3D7E774F6E3AQ35923384-D9C8FF67-FF3A-471E-9090-163FE58B3879Q35971980-C33D0DF3-8473-408A-BD98-23ECBDD025EE
P2860
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@en
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@nl
type
label
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@en
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@nl
prefLabel
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@en
Human alternatives to fetal bo ...... tromal cells from bone marrow.
@nl
P2093
P2860
P356
P1433
P1476
Human alternatives to fetal bo ...... stromal cells from bone marrow
@en
P2093
Andrea Hecker
Asli Kocaömer
Harald Klüter
Heinrich Lannert
Karen Bieback
P2860
P304
P356
10.1002/STEM.139
P577
2009-09-01T00:00:00Z